BHSc (Hons), University of Adelaide, 2016.
PhD Candidate in Medicine (Pharmacology), University of Adelaide, 2017-present.
My research is based in the area of Alzheimer's and Parkinson's disease, focusing primarily on the role of small-molecule inhibitors of beta amyloid and alpha synuclein aggregation and toxicity, as well as investigating the role of environmental factors on Parkinson's disease development and progression.
|2017||PhD Candidate||University of Adelaide, Adelaide|
|Chinese (Cantonese)||Can speak and understand spoken|
|English||Can read, write, speak, understand spoken and peer review|
|Japanese||Can understand spoken|
|—||University of Adelaide, Adelaide||Australia||Bachelor of Health Science|
|—||University of Adelaide, Adelaide||Australia||Bachelor of Health Science (Honours)|
|2017||Marsh, D., Das, S., Ridell, J., & Smid, S. (2017). Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2′,3′,4′-trihydroxyflavone (2-D08). Bioorganic and Medicinal Chemistry, 25(14), 3827-3834.
DOI Scopus2 WoS2 Europe PMC1